Annexin A2 Polyclonal Antibody
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0361901-V3
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $469.00
About this award
The University of Virginia awarded contract A207_PO-0361901-V3 to Life Technologies Corporation on October 10, 2026, for the procurement of laboratory reagents. The contract calls for the delivery of 469 units of Annexin A2 Polyclonal Antibody at a unit price of $1.00 per unit, resulting in a cumulative contract value of $469. The contracting organization is the University of Virginia, a state institution in Virginia.
Life Technologies Corporation, as the prime contractor, is responsible for supplying the Annexin A2 Polyclonal Antibody to the University of Virginia buyer. This contract represents a straightforward procurement of a single line item biological reagent commonly used in laboratory research and diagnostic applications. The modest contract value and single-unit pricing structure suggest this procurement may be part of a larger standing agreement or catalog purchase arrangement.
Line items
| Item | Total |
|---|---|
| Annexin A2 Polyclonal Antibody | $469.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0361901-V3?
Contract A207_PO-0361901-V3 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on October 10, 2026.
How much is contract A207_PO-0361901-V3 worth?
Its cumulative value is $469.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award